Id |
Subject |
Object |
Predicate |
Lexical cue |
T21 |
0-198 |
Sentence |
denotes |
In general, the identification of pulmonary GGOs or patients presenting with persistent fever should prompt additional diagnostic testing for differential diagnosis—including 18F-FDG PET/CT imaging. |
T22 |
199-461 |
Sentence |
denotes |
Here, we report the 18F-FDG PET/CT findings from four patients who were admitted to the Wuhan Union Hospital with lung GGOs and fever between January 13 and January 20, 2020—when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. |
T23 |
462-630 |
Sentence |
denotes |
A retrospective review of the patients’ medical history, clinical and laboratory data, as well as imaging findings (Table 1) strongly suggested a diagnosis of COVID-19. |
T24 |
631-710 |
Sentence |
denotes |
Table 1 General characteristics and PET/CT findings of four cases with COVID-19 |
T25 |
711-733 |
Sentence |
denotes |
Patient number 1 2 3 4 |
T26 |
734-757 |
Sentence |
denotes |
Sex Man Man Woman Woman |
T27 |
758-780 |
Sentence |
denotes |
Age, years 57 56 61 48 |
T28 |
781-910 |
Sentence |
denotes |
Clinical symptoms Fever, sore throat Fever, fatigue, dizziness Back pain, dry cough Fever, chill, dry cough, myalgia, and fatigue |
T29 |
911-954 |
Sentence |
denotes |
History of staying in Wuhan Yes Yes Yes Yes |
T30 |
955-1026 |
Sentence |
denotes |
WBC (× 109/L) (reference range 3.5–9.5 × 109/L) Normal 3.33 3.47 Normal |
T31 |
1027-1094 |
Sentence |
denotes |
Lymphocytes (%) (reference range 20–40%) Normal 17.5% Normal Normal |
T32 |
1095-1163 |
Sentence |
denotes |
HsCRP (mg/L) (reference range 0–5 mg/L) 6.65 23.6 Not available 12.2 |
T33 |
1164-1227 |
Sentence |
denotes |
Respiratory pathogens* Negative Negative Not available Negative |
T34 |
1228-1331 |
Sentence |
denotes |
PET/CT findings Number of affected lobes 2 (RUL, LLL) 5 (all lobes) 3 (RUL, RLL, LLL) 3 (RML, RLL, LLL) |
T35 |
1332-1428 |
Sentence |
denotes |
Lung CT features GGO GGO and consolidative opacities GGO GGO with interlobular septal thickening |
T36 |
1429-1452 |
Sentence |
denotes |
SUVmax 4.6 7.9 12.2 9.3 |
T37 |
1453-1610 |
Sentence |
denotes |
LN involvement Absent Right subclavian region, mediastinum Right supraclavicular region, mediastinum Right subclavian region, mediastinum, right hilar region |
T38 |
1611-1632 |
Sentence |
denotes |
LN SUVmax – 7 5.4 5.5 |
T39 |
1633-1683 |
Sentence |
denotes |
Concomitant diseases** Absent Absent Absent Absent |
T40 |
1684-1739 |
Sentence |
denotes |
*The following respiratory pathogens were investigated: |
T41 |
1740-1860 |
Sentence |
denotes |
Mycoplasma pneumoniae, Chlamydia pneumoniae, adenovirus, respiratory syncytial virus, and Coxsackie B-virus specific IgM |
T42 |
1861-1915 |
Sentence |
denotes |
**Including malignancies and other infectious diseases |
T43 |
1916-2172 |
Sentence |
denotes |
WBC, white blood cell; hsCRP, high-sensitivity C-reactive protein; LN, lymph node; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; GGO, ground-glass opacities; SUV, standardized uptake value |